Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: A multicenter study from Japan

Alimentary Pharmacology and Therapeutics

Volumn 26, Issue 1, 2007, Pages 69-77

  Miwa, H ^a   Sasaki, M ^b   Furuta, T ^c   Koike, T ^d   Habu, Y ^e   Ito, M ^f   Fujiwara, Y ^g   Wada, T ^b   Nagahara, A ^h   Hongo, M ⁱ   Chiba, T ^j   Kinoshita, Y ^k   Ohara, Shuichi ⁱ   Kusano, Motoyasu ^l   Hoshihara, Yoshio ^m   Kurosawa, Susumu ⁿ   Watanabe, Yusuke ^o   Joh, Takashi ^b   Higuchi, Kazuhide ^g   Haruma, Ken ^p   Manabe, Noriaki ^p   Adachi, Kyoichi ^k   Shimatani, Tomohiko ^q   Fujimoto, Kazuma ^r   more..

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e Saiseikai Noe Hospital   (Japan)

^f HIROSHIMA UNIVERSITY   (Japan)

^g OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h JUNTENDO UNIVERSITY   (Japan)

ⁱ TOHOKU UNIVERSITY HOSPITAL   (Japan)

^j KYOTO UNIVERSITY   (Japan)

^k SHIMANE UNIVERSITY   (Japan)

^l GUNMA UNIVERSITY HOSPITAL   (Japan)

^m Ministry of International Trade and Industry   (Japan)

ⁿ SAITAMA MEDICAL UNIVERSITY   (Japan)

^o International University of Health and Welfare Mita Hospital   (Japan)

^p KAWASAKI MEDICAL SCHOOL   (Japan)

^q HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^r SAGA UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RABEPRAZOLE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOATING; BLURRED VISION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SIDE EFFECT; SYMPTOM; THROMBOCYTE; URTICARIA;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AGED, 80 AND OVER; ENZYME INHIBITORS; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; JAPAN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 34250017988     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03350.x     Document Type: Article

References (22)

1. Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management - The Genval Workshop Report. Gut 1999 44 (Suppl. 2 S1 16.
2. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroephageal reflux disease. Am J Gastroenterol 2005 100 : 190 200.
3. Fass R. Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003 98 (Suppl S2 S7.
4. Quigley EMM, Hungin APS. Review article: quality of life issues in gastro-oesophageal reflux diseases. Aliment Pharmacol Ther 2005 22 (Suppl. 1 41 7.
5. Isolauri J, Luostarinen M, Isolauri E, Reinikainen P, Viljakka M, Keyrilainen O. Natural course of gastroesophageal reflux disease: 17-22 year follow-Up of 60 patients. Am J Gastroenterol 1997 92 : 37 41.
6. Amano Y, Ishimura N, Furuta K, et al. Interobserver agreement on classifying endoscopic diagnoses of nonerosive esophagitis. Endoscopy 2006 38 : 1032 5.
7. Labenz J, Nocon M, Lind T, et al. Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease. Am J Gastroenterol 2006 101 : 2457 62.
8. Miwa H, Minoo T, Hojo M, et al. Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases. Aliment Pharmacol Ther 2004 20 (Suppl. 1 112 7.
9. Fass R, Ofman JJ. Gastroesophageal reflux disease -should we adopt a new conceptual framework?. Am J Gastroenterol 2002 97 : 1901 9.
10. Hoshihara Y. Endoscopic findings of GERD. Nippon Rinsho 2004 62 : 1459 64.
11. Nakamura T, Shirakawa K, Masuyama H, Sugaya H, Hiraishi H, Terano A. Minimal change oesophagitis: a disease with characteristic differences to erosive oesophagitis. Aliment Pharmacol Ther 2005 21 : 19 26.
12. Hongo M. Minimal changes in reflux esophagitis: red ones and white ones. J Gastroenterol 2006 41 : 95 9.
13. Miner P, Orr W, Filippone J, Jokubaitis L, Sloan S. Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial. Am J Gastroenterol 2002 97 : 1332 9.
14. Fock KM, Teo EK, Ang TL, Chua TS, Ng TM, Tan YL. Rabeprazole vs esomeprazole in non-erosive gastroesophageal reflux disease: a randomized, double-blind study in urban asia. World J Gastroenterol 2005 11 : 3091 8.
15. Adachi K, Hashimoto T, Hamamoto N, et al. Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole. J Gastroenterol Hepatol 2003 18 : 1392 8.
16. Robinson M, Fitzgerald S, Hegedus R, Murthy A, Jokubaitis L. FAST Trial Investigators. Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis. Aliment Pharmacol Ther 2002 16 : 445 54.
17. Holtmann G, Bytzer P, Metz M, Loeffler V, Blum AL. A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2002 16 : 479 85.
18. Mishima I, Adachi K, Arima N, et al. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol 2005 40 : 1005 9.
19. Galmiche JP. Non-erosive reflux disease and atypical gastro-oesophageal reflux disease manifestations: treatment results. Drugs 2006 66 (Suppl. 1 7 13.
20. Bate CM, Green JRB, Axon ATR, et al. Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis. Aliment Pharmacol Ther 1997 11 : 755 63.
21. Venables TL, Newland RD, Patel AC, Hole J, Wilcock C, Turbitt ML. Omeprazole 10 milligrams once daily, Omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease-in general practice. Scand J Gastroenterol 1997 32 : 765 73.
22. Quigley EMM. New developments in the pathophysiology of gastro-oesophageal reflux disease(GERD): implications for patient management. Aliment Pharmacol Ther 2003 17 (Suppl. 2 43 51.